Advertisement
Advertisement

INAB

INAB logo

IN8bio, Inc. Common Stock

1.58
USD
Sponsored
-0.02
-1.25%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

1.56

-0.02
-0.95%

IN8bio, Inc. Common Stock Profile

About

IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.

Info & Links

CEO

William Ho

Headquarters

350 5th Avenue, Suite 5330
New York, NY 10118, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.in8bio.com

Auditor

CohnReznick LLP

Share holders

122

Employees

17

IN8bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

15.41M

Enterprise Value

-6.34M

Enterprise Value/EBITDA(ttm)

0.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.51

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-111.30%

Return on Invested Capital(ttm)

-119.62%

Return on Assets(ttm)

-88.07%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-17.13M

Net Income Available to Common(ttm)

-18.98M

Diluted EPS(ttm)

-4.45

Share Statistics

Beta (5Y Monthly)

0.04

52-Week Change

-68.63%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.85M

Dividend Yield

0.00%

Float4

8.42M

% Held by Insiders

14.50%

% Held by Institutions

92.05%

Balance Sheet

Total Cash(mrq)

21.94M

Total Cash Per Share(mrq)

2.23

Total Debt(mrq)

189.00K

Total Debt/Equity(mrq)

1.07%

Current Ratio(mrq)

8.82%

Quick Ratio(mrq)

8.82%

Book Value Per Share(mrq)

2.82

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.91

Free Cash Flow(ytd)

-12.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement